Use of Chamomile Infusion to Mitigate Radiotherapy-Induced Dry Desquamation in Head and Neck Cancer Patients

Amanda Gomes de Menêses,Elaine Barros Ferreira,Priscila de Souza Maggi Bontempo,Eliete Neves Silva Guerra,Paula Elaine Diniz dos Reis
DOI: https://doi.org/10.1177/15347354221105491
2022-07-28
Integrative Cancer Therapies
Abstract:Integrative Cancer Therapies, Volume 21, Issue , January-December 2022. Purpose:To evaluate the effect of using a compress with Chamomilla recutita infusion in the regression of dry desquamation and in the prevention of moist desquamation in head and neck cancer patients undergoing radiotherapy.Methods:A prospective intervention study was carried out from May 2019 to May 2021. In total, 43 participants were included, who were instructed to apply the compress with the infusion 3 times a day, after occurrence of dry desquamation. Skin evaluation took place daily from initiation of the intervention up to the end of radiotherapy.Results:All the participants presented dry desquamation regression, where 65.1% (95% CI 50.1-78.1) had total regression until the end of radiotherapy, with a mean of 9 days of regression. Only 34.9% (95% CI 21.8-49.9) of the participants developed moist desquamation by the end of the radiotherapy sessions, with a mean accumulated dose of ionizing radiation of 50.9 Gy.Conclusion:This study highlighted the potential clinical benefits of using Chamomilla recutita in the regression of dry desquamation and in the prevention of moist desquamation.
oncology,integrative & complementary medicine
What problem does this paper attempt to address?